Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyin Shi

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Surgical Oncology Clinics of North America|March 15, 2015
Role for radiation therapy in melanomaWenyin Shi
Journal of Surgical Oncology|December 9, 2024
Common on: "Obesity Increases the Risk of Major Wound Complications Following Pelvic Resection for Bone Sarcoma"Fengle Yan, Wenyin Shi
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumorsDietmar W Siemann, Wenyin Shi
Anticancer Research|March 16, 2004
Simultaneous targeting of VEGF message and VEGF receptor signaling as a therapeutic anticancer approachWenyin Shi, Dietmar W Siemann
Chinese Clinical Oncology|August 27, 2017
PrefaceWenyin Shi, Joshua D Palmer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene RearrangementWenyin Shi, Adam P Dicker
Anticancer Research|August 30, 2008
Dual targeting of tumor vasculature: combining Avastin and vascular disrupting agents (CA4P or OXi4503)Dietmar W Siemann, Wenyin Shi
Anticancer Research|November 29, 2005
Preclinical studies of the novel vascular disrupting agent MN-029Wenyin Shi, Dietmar W Siemann
In Vivo (Athens, Greece)|November 10, 2005
Targeting the tumor vasculature: enhancing antitumor efficacy through combination treatment with ZD6126 and ZD6474Wenyin Shi, Dietmar W Siemann
Seminars in Radiation Oncology|January 10, 2003
Targeting the tumor blood vessel network to enhance the efficacy of radiation therapyDietmar W Siemann, Wenyin Shi
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Surgical Oncology Clinics of North America|March 15, 2015
Role for radiation therapy in melanomaWenyin Shi
Journal of Surgical Oncology|December 9, 2024
Common on: "Obesity Increases the Risk of Major Wound Complications Following Pelvic Resection for Bone Sarcoma"Fengle Yan, Wenyin Shi
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumorsDietmar W Siemann, Wenyin Shi
Anticancer Research|March 16, 2004
Simultaneous targeting of VEGF message and VEGF receptor signaling as a therapeutic anticancer approachWenyin Shi, Dietmar W Siemann
Chinese Clinical Oncology|August 27, 2017
PrefaceWenyin Shi, Joshua D Palmer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene RearrangementWenyin Shi, Adam P Dicker
Anticancer Research|August 30, 2008
Dual targeting of tumor vasculature: combining Avastin and vascular disrupting agents (CA4P or OXi4503)Dietmar W Siemann, Wenyin Shi
Anticancer Research|November 29, 2005
Preclinical studies of the novel vascular disrupting agent MN-029Wenyin Shi, Dietmar W Siemann
In Vivo (Athens, Greece)|November 10, 2005
Targeting the tumor vasculature: enhancing antitumor efficacy through combination treatment with ZD6126 and ZD6474Wenyin Shi, Dietmar W Siemann
Seminars in Radiation Oncology|January 10, 2003
Targeting the tumor blood vessel network to enhance the efficacy of radiation therapyDietmar W Siemann, Wenyin Shi
Pageof 18